New FDA approved indications for lenvatinib, pembro, and apalutamide
Sep 19, 2019
16:35
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Discussion of FDA's approval of lenvatinib & pembrolizumab for endometrial cancer followed by a comparison of TITAN v. ENZAMET prompted by apalutamide's latest approval.
